Business Context and Reporting Period
This Form 8-K filing by Labcorp Holdings Inc. reports the final results of the 2026 Annual Meeting of Shareholders held on May 21, 2026. The date of record for determining voting eligibility was March 26, 2026.
Key Financial Metrics
This filing is a current report regarding corporate governance and shareholder voting. It does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity metrics.
Material Changes and Voting Results
As of the record date, there were 82,187,046 shares issued and outstanding. A quorum was established with 76,382,627 shares represented. The following proposals were voted upon:
- Proposal 1 (Election of Directors): All 11 nominees were elected to the Board of Directors. Notable voting patterns included:
- Garheng Kong, M.D., Ph.D. received the highest number of "Against" votes (20,110,931) and "Abstentions" (294,749) among the nominees, though still secured a majority "For" vote (50,153,535).
- Adam H. Schechter and Kerrii B. Anderson received the second and third highest "Against" votes (4,958,626 and 5,292,331, respectively).
- Other nominees received significantly fewer "Against" votes, ranging from 34,977 to 70,221.
- Proposal 2 (Say-on-Pay): Shareholders approved the advisory vote on executive compensation with 66,519,291 votes "For" and 3,735,777 votes "Against".
- Proposal 3 (Auditor Ratification): Shareholders ratified the appointment of Deloitte & Touche LLP as the independent registered public accounting firm for the year ending December 31, 2026, with 76,291,589 votes "For" and only 53,650 votes "Against".
Guidance, Outlook, and Risks
The filing does not provide management commentary, financial guidance, outlook, or specific risk factors. It strictly details the certified vote counts for the Annual Meeting.
Investor Verification Checklist
- Verify the specific reasons for the elevated "Against" votes for directors Garheng Kong, Adam H. Schechter, and Kerrii B. Anderson by reviewing the definitive Proxy Statement filed on April 10, 2026.
- Confirm the term expiration for the newly elected directors (2027 Annual Meeting).
- Review the 2026 Annual Report (Form 10-K) for the financial metrics and operational context not included in this 8-K.